Skip to content
About Us
Menu Toggle
Overview
Founder
Executives
Advisors
Technologies
Menu Toggle
Overview
Multi-arm linkers
Cytotoxic drug bundles
Dual-drug cytotoxic drug bundles
Chelator bundles
scFv-based antibody drug conjugates
CHO-TEM antibody drug conjugates
Antibody radionuclide conjugates
Products
Menu Toggle
Overview
TE-1146
TE-1182
Anti-CA19-9 ARC
News and Honours
Menu Toggle
In-Depth Interview with Chairman Tse-Wen Chang: Leading T-E Meds in Advancing ADC Technology
Join our presentation at the 16th Annual World ADC – San Diego 2025!
T-E Meds Shortlisted for World ADC Awards, Showcasing Global Recognition of Its Innovative Platform and Pipeline
Congratulations! T-E Meds is proud to be recognized by the Ministry of Economic Affairs as a certified Biotech & Pharmaceutical Company!
Join our presentation at the Asia BIO Innovation Summit 2025
TE-1146 drug development was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan
Join our presentation at the BIO Asia-Taiwan 2025 Conference
T-E Meds and Asymchem Join Forces to Drive Innovation in Drug Conjugates and Explore the Future of Targeted Therapeutics
Join our presentation at the World ADC Asia 2025 Conference
【Reported by Taiwan Global Bio Monthly】The President, Dr. Tse-Wen Chang was invited as a keynote speaker at Biologics World Taiwan 2025
T-E Meds and Orient EuroPharma Forge Licensing Agreement for TE-1146
Older News Items
Recruitment Notice
Language
Menu Toggle
English
繁體中文
About Us
Menu Toggle
Overview
Founder
Executives
Advisors
Technologies
Menu Toggle
Overview
Multi-arm linkers
Cytotoxic drug bundles
Dual-drug cytotoxic drug bundles
Chelator bundles
scFv-based antibody drug conjugates
CHO-TEM antibody drug conjugates
Antibody radionuclide conjugates
Products
Menu Toggle
Overview
TE-1146
TE-1182
Anti-CA19-9 ARC
News and Honours
Menu Toggle
In-Depth Interview with Chairman Tse-Wen Chang: Leading T-E Meds in Advancing ADC Technology
Join our presentation at the 16th Annual World ADC – San Diego 2025!
T-E Meds Shortlisted for World ADC Awards, Showcasing Global Recognition of Its Innovative Platform and Pipeline
Congratulations! T-E Meds is proud to be recognized by the Ministry of Economic Affairs as a certified Biotech & Pharmaceutical Company!
Join our presentation at the Asia BIO Innovation Summit 2025
TE-1146 drug development was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan
Join our presentation at the BIO Asia-Taiwan 2025 Conference
T-E Meds and Asymchem Join Forces to Drive Innovation in Drug Conjugates and Explore the Future of Targeted Therapeutics
Join our presentation at the World ADC Asia 2025 Conference
【Reported by Taiwan Global Bio Monthly】The President, Dr. Tse-Wen Chang was invited as a keynote speaker at Biologics World Taiwan 2025
T-E Meds and Orient EuroPharma Forge Licensing Agreement for TE-1146
Older News Items
Recruitment Notice
Language
Menu Toggle
English
繁體中文
Recruitment Notices
Scroll to Top
